Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00034125 · ClinicalTrials.gov registry record · Phase 3
Phase 3 Study of LY353381 Vs Tamoxifen in Women With Locally Advanced or Metastatic Breast Cancer.
A Phase 3 study, sponsored by Eli Lilly and Company.
- Completed
- Registry status
- Phase 3
- Development phase
NCT00034125: Completed Phase 3 study, sponsored by Eli Lilly and Company.
NCT00034125 is a Phase 3 study that has completed, run by Eli Lilly and Company. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00034125, a Phase 3 study, has completed, sponsored by Eli Lilly and Company.
- COMPLETED
- Registry status
- Phase 3
- Development phase
Study Summary
To determine the safety and efficacy of LY353381 when compared to tamoxifen in women with advanced or metastatic breast cancer.
Interventions
- DRUG tamoxifen
- DRUG LY353381
Trial Details
| Field | Value |
|---|---|
| Phase | Phase 3 |
What the finished NCT00034125 record still lists
NCT00034125 is an interventional study that assigns participants to a tested intervention. An enrollment target was not published in the registry record, which is common for early-stage or observational entries.
The record links to 0 conditions, and to 2 interventions - of which tamoxifen is the first listed.
NCT00034125 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00034125 about?
NCT00034125 is a clinical study titled "Phase 3 Study of LY353381 Vs Tamoxifen in Women With Locally Advanced or Metastatic Breast Cancer.". To determine the safety and efficacy of LY353381 when compared to tamoxifen in women with advanced or metastatic breast cancer.
What is the current status of trial NCT00034125?
This trial is currently completed. It is a Phase 3 study.
What interventions are being tested in trial NCT00034125?
The interventions under investigation include: tamoxifen (DRUG), LY353381 (DRUG).
Who is sponsoring clinical trial NCT00034125?
This trial is sponsored by Eli Lilly and Company, which has 1,341 total clinical trials registered on ClinicalTrials.gov.